Litcius/Paper detail

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Hany Elmariah, Salman Otoukesh, Ambuj Kumar, Haris Ali, Shukaib Arslan, Geoffrey Shouse, Hoda Pourhassan, Taiga Nishihori, Rawan Faramand, Asmita Mishra, Farhad Khimani, Hugo F. Fernández, Aleksandr Lazaryan, Michael L. Nieder, Lia Perez, Hien Liu, Ryotaro Nakamura, Joseph Pidala, Guido Marcucci, Stephen J. Forman, Claudio Anasetti, Frederick L. Locke, Nelli Bejanyan, Monzr M. Al Malki

2023Transplantation and Cellular Therapy15 citationsDOI

Topics & Concepts

MedicineTacrolimusTransplantationGraft-versus-host diseaseInternal medicineCyclophosphamideGastroenterologyHematopoietic stem cell transplantationCohortSurgeryChemotherapyHematopoietic Stem Cell TransplantationPolyomavirus and related diseasesCytomegalovirus and herpesvirus research